CHARISMA

Print

2006

CHARISMA

Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management & Avoidance)

A phase III, Multicentre, Multinational, Randomised, Parrallel Group, Double-Blind Trial of chlopidogrol versus Placebo in High-Risk Patients aged over 45 Years and Older, at Risk of Atherothrombotic Events, and who are recieveing background therapy including low-dose ASA.

PREVAIL

Prevention of Venous Thrombo Embolism after Acute Ischemic Stroke with Low Molecular Weight Heparin)To demonstrate superiority of enoxaparin compared to unfractionated heparin (UFH) in the prevention of Venous Thromboembolism (VTE) following acute ischemic stroke.            
Last Updated ( Tuesday, 25 August 2015 13:15 )